By Matt Grossman
Boston Scientific Corp. on Wednesday adjusted its full-year earnings guidance by narrowing the forecast range compared with previous guidance.
For the full year, the medical-devices company said it now expects sales growth of 19% to 20% compared with last year, and adjusted earnings of $1.60 a share to $1.62 a share. In July, Boston Scientific had forecast adjusted earnings of $1.58 a share to $1.62 a share for the full year.
In the fourth quarter, Boston Scientific anticipates year-over year sales growth of 13% to 17% and adjusted earnings of 43 cents to 45 cents a share.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
10-27-21 0659ET